T cell receptor recognizing tetanus toxoid peptide-MHC class II complex (TCR-TT-MHCII)

The T cell receptor (TCR) on CD4+ T cells recognizing the tetanus peptide–MHC class II complex is a fundamental mediator of the adaptive immune response against Clostridium tetani. This receptor specifically binds to immunodominant peptides derived from tetanus toxoid, such as the universal p2 epitope (residues 830–844), when presented by Major Histocompatibility Complex (MHC) class II molecules, typically HLA-DR, on the surface of antigen-presenting cells (Demotz et al., 1989, J Immunol; Panina-Bordignon et al., 1989, Eur J Immunol). This interaction is central to the efficacy of the tetanus vaccine, as it triggers the activation and expansion of helper T cells that facilitate B cell maturation and high-affinity antibody production. In therapeutic research, this TCR is frequently used as a model system to study T cell memory and as a positive control in assays evaluating the immunogenicity of novel biologics (Rosendahl et al., 2021, Front Immunol). Additionally, tetanus-specific TCR sequences are being investigated for use in TCR-engineered T cell therapies to enhance anti-tumor immunity by providing potent CD4+ helper signals. The signaling initiated by this TCR involves the recruitment of the CD3 complex and subsequent activation of downstream pathways like the MAPK and NF-kappaB cascades.

Other names

Tetanus-specific T cell receptorTT-specific TCRCD4+ TCR for tetanus peptideTetanus toxoid-specific TCRTCR recognizing tetanus toxin 830–844

Antigen-specific recognition of peptide-MHC II complexes leading to T cell activation and immune orchestration.